INTELLIGENCE IN ACTION

A Better Partner for Community Pharmacists

With over 70 percent of all prescriptions processed electronically, e-prescribing is proof that interoperability is happening. But with many prescriptions still requiring manual intervention, there is still work to be done to improve accuracy and efficiency across the network. Over the past year, we have been actively engaged with the National Community Pharmacists Association and more than 125 customers and industry partners across the network to identify opportunities for improvements and work together to improve e-prescribing to the benefit of everyone, including pharmacists.

To learn more about how Surescripts is improving e-prescribing for community pharmacists, watch the video below to hear directly from our CEO Tom Skelton. 



As we continue to celebrate American Pharmacists Month we look forward to seeing you next week at the 2016 NCPA Annual Convention where you can visit Surescripts at booth #847. You can also swing by the Technology Seminar to hear from Surescripts’ pharmacy expert, Ken Whittemore on our latest e-prescribing capabilities, RxChange and CancelRx.

Join the conversation below or reach out to @Surescripts on social media using #NCPA2016 during the NCPA Annual Convention and using #APhM2016 all month long!

Surescripts at NCPA

You may also like

The Rise of Electronic Prescribing for Controlled Substances: How Does Your State Rank?

The Centers for Disease Control and Prevention (CDC) recently released new clinical guidelines to improve the process for prescribing controlled substances. However, there is another important step providers can take to combat the nation's opioid epidemic: digitizing the process with Electronic Prescribing for Controlled Substances (EPCS). read more

Alert: New E-Prescription Quality Guidelines

Six years ago, Surescripts implemented the Clinical Quality Management program to measure, monitor and improve the quality of e-prescriptions flowing through the network. As part of this initiative, we conducted an analysis that revealed the absence of widely recognized guidelines and best practices for e-prescription messaging data quality. read more

JAMA Internal Medicine Study Provides Wake-Up Call: Improving e-Prescription Safety and Standards Adoption

With 77 percent of all prescriptions in the U.S. being routed electronically in 2015, e-prescribing is now the industry norm. However, there is still room for improvement when it comes to e-prescription quality and the user experience. One area for continuing quality improvement is the Notes field, as described in a recent Surescripts-led study published in the JAMA Internal Medicine last month. read more

Intelligence in Action, delivered to your inbox